Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Jean Perrin
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Age\> 18 years.
Patient suffering from a breast tumor, regardless of the stage and size
Patient requiring neoadjuvant chemotherapy
Patient has the ability to undergo 18F-FDG-PET at baseline, at end of cycle 1 and at the end of neoadjuvant treatment before surgery
Compulsory affiliation to a social security system.
Obtaining informed consent in writing, signed and dated.
You may not be if
Patient with cognitive or psychiatric disorders.
Patient deprived of liberty by a court or administrative.
Patient with signs against the achievement of MRI, mammography and ultrasound
Patient metastatic
Patient with prior chemotherapy, radiotherapy and hormone therapy for her breast cancer
Pregnant women, current lactation
Patient suffering from uncontrolled diabetes (\> 11 mmol / L)
Clareo Health | Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
